Arbesda RespiClick (fluticasone propionate/salmeterol xinafoate)

pCPA File Number: 21073

Negotiation Status:

Concluded without agreement

Indication(s):

Asthma

Sponsor/Manufacturer:

Teva Canada Ltd.

CDA-AMC Project Number:

SR0540-000

pCPA Engagement Letter Issued:

2019-04-12

Negotiation Process Concluded:

2019-07-31